sur HBM Healthcare Investments AG (ETR:CH001262)
HBM Healthcare Investments AG Reports Monthly Performance Figures
HBM Healthcare Investments AG released its key performance figures for February 2026, highlighting notable changes in its financial metrics. As of February 28, 2026, the Net Asset Value (NAV) per share stood at CHF 275.58, reflecting a month-to-date (MTD) decline of 1.6% and a calendar year-to-date (CYTD) decrease of 1.9%. The company's share price was recorded at CHF 222.00, marking a 7.5% drop MTD and a 2.0% decline CYTD.
Despite these declines, the figures also note a significant improvement of 15.8% in the fiscal year-to-date (FYTD) for NAV and a 26.8% increase for the share price. The total net assets were reported at CHF 1,826 million. HBM, headquartered in Zug, Switzerland, continues to monitor market conditions closely as it navigates its investment strategy.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de HBM Healthcare Investments AG